Clinical Trial for Prostate Cancer

This study has been completed.
Sponsor:
Information provided by:
Oakwood Laboratories, LLC
ClinicalTrials.gov Identifier:
NCT00076531
First received: January 26, 2004
Last updated: January 24, 2008
Last verified: January 2008
  Purpose

Phase III trial using an injectable for treatment of prostate cancer.


Condition Intervention Phase
Prostate Cancer
Drug: Leuprolide Acetate for Injectable Suspension 22.5 mg
Phase 3

Study Type: Interventional
Study Design: Endpoint Classification: Safety/Efficacy Study
Masking: Open Label
Primary Purpose: Treatment

Resource links provided by NLM:


Further study details as provided by Oakwood Laboratories, LLC:

Study Start Date: December 2003
Primary Completion Date: November 2004 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   40 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00076531

Sponsors and Collaborators
Oakwood Laboratories, LLC
Investigators
Study Chair: James A. Page, M.D. Oakwood Laboratories, LLC
  More Information

Additional Information:
No publications provided

ClinicalTrials.gov Identifier: NCT00076531     History of Changes
Other Study ID Numbers: OL-007
Study First Received: January 26, 2004
Last Updated: January 24, 2008
Health Authority: United States: Food and Drug Administration

Keywords provided by Oakwood Laboratories, LLC:
Prostate
Cancer
PSA
Leuprolide

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms
Neoplasms by Site
Prostatic Diseases
Urogenital Neoplasms
Leuprolide
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Fertility Agents
Fertility Agents, Female
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on October 30, 2014